丁建勇-JITC：复旦大学中山医院团队发现新的肺癌表观遗传干预靶点

参考文献：

[1]Yong-Qiang A, Jian G, Chun J, et al. ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3[J]. Journal for ImmunoTherapy of Cancer, 2023, 11(12): e007766.

[2]Jia J, Absmeier E, Holton N, et al. The interaction of DNA repair factors ASCC2 and ASCC3 is affected by somatic cancer mutations[J]. Nature Communications, 2020, 11: 5535.

[3]Liao C, Talluri S, Mu S, et al. Flap Structure-Specific Endonuclease 1 Coordinates with a Helicase (ASCC3) to Drive Genomic Instability, Proliferation and Poor Clinical Outcome in Myeloma[J]. Blood, 2022, 140(Supplement 1): 9963.

本文作者丨谭硕